All Human medicines articles – Page 2
-
Meeting Report
HM3: Evolution of EMA-EUnetHTA collaboration across decision makers
This session focused on the evolution of the European Medicines Agency (EMA) and The European Network for Health Technology Assessment (EUnetHTA) collaboration.
-
Meeting Report
HM1: Spotlight on CEE – challenges and opportunities in the region
The first session of this virtual symposium was opened by Eva Kopecna, who introduced three speakers, two of whom represented two different regulatory agencies – the Czech State Institute for Drug Control (SÚKL), which is part of the EU regulatory community, and the Russian State Institute of Drugs and Good Practices (SID&GP).
- Previous Page
- Page1
- Page2
- Next Page